<p>佛罗里达州坦帕，2025 年 4 月 4 日（GLOBE NEWSWIRE）——Better Choice Company, Inc.（纽约证券交易所美国：BTTR）（“Better Choice” 或 “公司”），一家宠物健康和保健公司，董事长 Michael Young 今天向股东提供了关于其 SRx Health Solutions, Inc.（“SRx Health”）收购的更新，并对 SRx Health 最近的债转股交易进行了评论。</p>
<p>Better Choice 的董事长 Michael Young 表示：“我们很高兴 SRx Health 的一位战略合作伙伴成为股东，因为我们即将完成交易。在交易保护措施到位的情况下，SRx Health 发行的新股不会影响 Better Choice 向 SRx Health 发行的股份。无论 SRx Health 有多少股东，向其发行的股份保持不变。这项债转股交易通过减少 400 万加元的债务，增强了合并公司的实力。此外，我们还有一位强大且支持的新合作伙伴作为股东。”</p>
<p>这项投资待 SRx Health Solutions 与 Better Choice Company 的合并完成，预计将在 4 月底进行。合并后，双方将成为一家领先的全球健康和保健公司，为宠物、个人和家庭提供更优质的产品和解决方案。</p>
<p><strong>关于 Better Choice Company Inc.</strong></p>
<p>Better Choice Company Inc.是一家快速增长的宠物健康和保健公司，致力于引领行业向帮助狗和猫过上更健康、更快乐、更长寿的生活的宠物产品和服务转型。我们采取一种基于营养的替代方法来处理宠物健康，相较于传统的狗和猫食品，定位我们的品牌组合以受益于日益增长的宠物人性化和消费者对健康与保健的关注。我们在销售值得信赖的宠物健康和保健产品方面有着数十年的成功记录，并利用我们建立的数字足迹为宠物家长提供知识，以便他们能够做出明智的宠物健康决策。我们大部分的狗粮、猫粮和零食都以 Halo 品牌销售，分别专注于提供可持续来源的干粮和由真实整肉制成的罐头食品，以及经过最小加工的生食狗粮和零食。有关更多信息，请访问 https://www.betterchoicecompany.com。</p>
<p><strong>关于 SRx Health</strong></p>
<p>SRx 作为一家加拿大医疗服务提供商，专注于制药行业的特殊药房领域。SRx 作为国家特殊药房提供商，专注于管理患者的医疗旅程，从急性药物需求到慢性和罕见疾病管理。这一独特的关注点使 SRx 能够提供更全面和集成的解决方案，满足患者和关键医疗利益相关者的需求。我们的全方位端到端服务包括批发/分销设施、患者支持计划、输液诊所、零售药房、共同设计的临床项目、临床试验和诊断服务。我们的战略增长计划具有前瞻性，围绕与制药制造商和开处方医生的合作增加展开。我们特别关注慢性和罕见疾病日益扩大的市场，目标是与封闭和有限分销网络相关的特殊药物。我们的目标是扩大其分销并改善可及性。我们的总体目标是将我们在加拿大中型人口中心的特殊药房数量从 34 个提升到 100 个，从而增强医疗服务的范围并建立新的行业基准。在 SRx 发展的下一阶段，我们计划将我们的业务扩展到加拿大以外。利用我们全面的方法，我们希望在全球范围内简化医疗服务。有关 SRx 的更多信息，请访问 <strong>https://www.srxhealth.ca</strong> <strong>。</strong></p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含根据 1995 年《私人证券诉讼改革法》定义的前瞻性声明。与我们相关的 “相信”、“可能”、“估计”、“继续”、“预期”、“打算”、“应该”、“计划”、“可以”、“目标”、“潜在”、“很可能”、“将”、“期望” 等类似表达，旨在识别前瞻性声明。公司在很大程度上基于我们对未来事件和财务趋势的当前预期和预测来制定这些前瞻性声明，我们认为这些可能影响我们的财务状况、经营结果、商业战略和财务需求。某些或所有这些前瞻性声明所预期的结果可能无法实现。有关公司风险因素的更多信息包含在我们向 SEC 提交的文件中。我们在此作出的任何前瞻性声明仅在声明之日有效。可能导致我们实际结果有所不同的因素或事件可能会不时出现，我们无法预测所有这些因素。公司没有义务公开更新任何前瞻性声明，无论是由于新信息、未来发展还是其他原因，除非法律要求。</p>
<p><strong>公司联系方式：</strong></p>
<p>Better Choice Company, Inc.</p>
<p>Kent Cunningham, 首席执行官</p>
<p><strong>投资者联系方式：</strong></p>
<p>KCSA 战略传播</p>
<p>Valter Pinto, 董事总经理</p>
<p>电话：212-896-1254</p>
<p>Valter@KCSA.com</p>

BTTR

SRXH

<p>Better Choice 公司董事长迈克尔·杨（Michael Young）就收购 SRx Health Solutions 提供了最新进展，强调了一项最近的债转股交易，该交易减少了 400 万加元的债务。此次合并预计将在四月底完成，旨在创建一家领先的全球宠物和家庭健康与保健公司。杨对战略合作伙伴成为股东表示兴奋，强调新股权不会影响已发行给 SRx Health 的股份。Better Choice 专注于基于营养的宠物健康产品，而 SRx 则专注于加拿大的专业药房服务</p>

<p>TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, Chairman, Michael Young, today provides shareholders with a update on its SRx Health Solutions, Inc. (“SRx Health”) acquisition and comments on SRx Health’s recent debt-to-equity transaction.</p>
<div class="lb-trans"><p>佛罗里达州坦帕，2025 年 4 月 4 日（GLOBE NEWSWIRE）——Better Choice Company, Inc.（纽约证券交易所美国：BTTR）（“Better Choice” 或 “公司”），一家宠物健康和保健公司，董事长 Michael Young 今天向股东提供了关于其 SRx Health Solutions, Inc.（“SRx Health”）收购的更新，并对 SRx Health 最近的债转股交易进行了评论。</p>
</div><p>Michael Young, Chairman of Better Choice, commented, “We are excited to have one of SRx Health’s strategic partners become an equity holder, as we near the closing of our transaction together. With the deal collar in place, the new equity issued by SRx Health will not effect the shares issued from Better Choice to SRx Health. The shares issued to SRx Health remain the same regardless of how many shareholders they have. This debt-to-equity transaction strengthens the combined company with debt reduced by CAD$4 million. As well, we have a strong and supportive new partner as an equity holder.”</p>
<div class="lb-trans"><p>Better Choice 的董事长 Michael Young 表示：“我们很高兴 SRx Health 的一位战略合作伙伴成为股东，因为我们即将完成交易。在交易保护措施到位的情况下，SRx Health 发行的新股不会影响 Better Choice 向 SRx Health 发行的股份。无论 SRx Health 有多少股东，向其发行的股份保持不变。这项债转股交易通过减少 400 万加元的债务，增强了合并公司的实力。此外，我们还有一位强大且支持的新合作伙伴作为股东。”</p>
</div><p>This investment is pending the closing of the merger between SRx Health Solutions and Better Choice Company, which is scheduled for late-April. Upon closing, the combined companies will emerge as a leading global health and wellness company, delivering enhanced products and solutions for pets, people, and families.</p>
<div class="lb-trans"><p>这项投资待 SRx Health Solutions 与 Better Choice Company 的合并完成，预计将在 4 月底进行。合并后，双方将成为一家领先的全球健康和保健公司，为宠物、个人和家庭提供更优质的产品和解决方案。</p>
</div><p><strong>About Better Choice Company Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 Better Choice Company Inc.</strong></p>
</div><p>Better Choice Company Inc. is a rapidly growing pet health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier, and longer lives. We take an alternative, nutrition-based approach to pet health relative to conventional dog and cat food offerings and position our portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. We have a demonstrated, multi-decade track record of success selling trusted pet health and wellness products and leverage our established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. We sell the majority of our dog food, cat food and treats under the Halo brand, which is focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats. For more information, please visit https://www.betterchoicecompany.com.</p>
<div class="lb-trans"><p>Better Choice Company Inc.是一家快速增长的宠物健康和保健公司，致力于引领行业向帮助狗和猫过上更健康、更快乐、更长寿的生活的宠物产品和服务转型。我们采取一种基于营养的替代方法来处理宠物健康，相较于传统的狗和猫食品，定位我们的品牌组合以受益于日益增长的宠物人性化和消费者对健康与保健的关注。我们在销售值得信赖的宠物健康和保健产品方面有着数十年的成功记录，并利用我们建立的数字足迹为宠物家长提供知识，以便他们能够做出明智的宠物健康决策。我们大部分的狗粮、猫粮和零食都以 Halo 品牌销售，分别专注于提供可持续来源的干粮和由真实整肉制成的罐头食品，以及经过最小加工的生食狗粮和零食。有关更多信息，请访问 https://www.betterchoicecompany.com。</p>
</div><p><strong>About SRx Health</strong></p>
<div class="lb-trans"><p><strong>关于 SRx Health</strong></p>
</div><p>SRx operates as a Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry. Distinguishing itself as a National Specialty Pharmacy provider, SRx concentrates on overseeing a patient's healthcare journey, spanning from acute pharmaceutical needs to chronic and rare disease management. This unique focus positions SRx to deliver a more holistic and integrated solution, catering to the requirements of both patients and key healthcare stakeholders. Our all-encompassing end-to-end offerings include wholesale/distribution facilities, patient support programs, infusion clinics, retail pharmacies, co-designed clinical programs, clinical trials, and diagnostic services. Our strategic growth plan is forward-thinking and revolves around fostering increased collaboration with pharmaceutical manufacturers and prescribers. With a specific emphasis on the expanding market of chronic and rare diseases, we target specialty drugs associated with closed and limited distribution networks. The objective is to broaden their distribution and improve accessibility. Our overarching goal is to elevate our current presence from 34 to 100 specialty pharmacy locations across mid-sized population centers throughout Canada, thereby enhancing the scope of healthcare services and establishing new industry benchmarks. In the subsequent phase of SRx's evolution, we aim to extend our reach beyond the borders of Canada. Leveraging our comprehensive approach, we aspire to simplify healthcare on a global scale. For more information on SRx, please visit <strong>https://www.srxhealth.ca</strong> <strong>.</strong></p>
<div class="lb-trans"><p>SRx 作为一家加拿大医疗服务提供商，专注于制药行业的特殊药房领域。SRx 作为国家特殊药房提供商，专注于管理患者的医疗旅程，从急性药物需求到慢性和罕见疾病管理。这一独特的关注点使 SRx 能够提供更全面和集成的解决方案，满足患者和关键医疗利益相关者的需求。我们的全方位端到端服务包括批发/分销设施、患者支持计划、输液诊所、零售药房、共同设计的临床项目、临床试验和诊断服务。我们的战略增长计划具有前瞻性，围绕与制药制造商和开处方医生的合作增加展开。我们特别关注慢性和罕见疾病日益扩大的市场，目标是与封闭和有限分销网络相关的特殊药物。我们的目标是扩大其分销并改善可及性。我们的总体目标是将我们在加拿大中型人口中心的特殊药房数量从 34 个提升到 100 个，从而增强医疗服务的范围并建立新的行业基准。在 SRx 发展的下一阶段，我们计划将我们的业务扩展到加拿大以外。利用我们全面的方法，我们希望在全球范围内简化医疗服务。有关 SRx 的更多信息，请访问 <strong>https://www.srxhealth.ca</strong> <strong>。</strong></p>
</div><p><strong>Forward Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.</p>
<div class="lb-trans"><p>本新闻稿包含根据 1995 年《私人证券诉讼改革法》定义的前瞻性声明。与我们相关的 “相信”、“可能”、“估计”、“继续”、“预期”、“打算”、“应该”、“计划”、“可以”、“目标”、“潜在”、“很可能”、“将”、“期望” 等类似表达，旨在识别前瞻性声明。公司在很大程度上基于我们对未来事件和财务趋势的当前预期和预测来制定这些前瞻性声明，我们认为这些可能影响我们的财务状况、经营结果、商业战略和财务需求。某些或所有这些前瞻性声明所预期的结果可能无法实现。有关公司风险因素的更多信息包含在我们向 SEC 提交的文件中。我们在此作出的任何前瞻性声明仅在声明之日有效。可能导致我们实际结果有所不同的因素或事件可能会不时出现，我们无法预测所有这些因素。公司没有义务公开更新任何前瞻性声明，无论是由于新信息、未来发展还是其他原因，除非法律要求。</p>
</div><p><strong>Company Contact:</strong></p>
<div class="lb-trans"><p><strong>公司联系方式：</strong></p>
</div><p>Better Choice Company, Inc.</p>
<div class="lb-trans"><p>Better Choice Company, Inc.</p>
</div><p>Kent Cunningham, CEO</p>
<div class="lb-trans"><p>Kent Cunningham, 首席执行官</p>
</div><p><strong>Investor Contact:</strong></p>
<div class="lb-trans"><p><strong>投资者联系方式：</strong></p>
</div><p>KCSA Strategic Communications</p>
<div class="lb-trans"><p>KCSA 战略传播</p>
</div><p>Valter Pinto, Managing Director</p>
<div class="lb-trans"><p>Valter Pinto, 董事总经理</p>
</div><p>T: 212-896-1254</p>
<div class="lb-trans"><p>电话：212-896-1254</p>
</div><p>Valter@KCSA.com</p>
<div class="lb-trans"><p>Valter@KCSA.com</p>
</div>

Better Choice 公司主席就 SRx Health 收购向股东提供了最新情况，并对近期的债转股交易发表了评论